Author

S. E. Steane

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

D. A. Carter· 1 shared H. Bielefeldt-Ohmann· 1 shared L. A. Gallo· 1 shared L. Ryan· 1 shared M. E. Reichelt· 1 shared M. Flint· 1 shared S. L. Walton· 1 shared S. L. Young· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

D. A. Carter

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Sotagliflozin, a dual SGLT1/2 inhibitor, improves cardiac outcomes in a mouse model of early heart failure without diabetes

S. L. Young, L. Ryan, T. P. Mullins, M. Flint, S. E. Steane, S. L. Walton, H. Bielefeldt-Ohmann, D. A. Carter, M. E. Reichelt, L. A. Gallo

This study shows that sotagliflozin, a dual SGLT1/2 inhibitor, improves cardiac outcomes in non-diabetic mice with heart failure but not in diabetic mice with proximal tubular damage.

bioRxiv · Aug 15, 2020 · PreprintPharmacology & Toxicology